Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 195 | 205 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
CYP19A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Hypogonadotropic Hypogonadism Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 67 | 46 |
|
Invitae Disorders of Sex Development Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 88 | 53 |
|
Genome-Nilou Lab Iran | 110 | 146 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
Premature Ovarian Failure (POF) Panel PreventionGenetics, part of Exact Sciences United States | 19 | 21 |
|
qGenEx Sex development disorders Quantitative Genomic Medicine Laboratories, SL Spain | 45 | 48 |
|
46,XX Disorders of Sex Development/Complete Gonadal Dysgenesis Panel Genetic Services Laboratory University of Chicago United States | 9 | 11 |
|
Panel of premature ovarian failure. NGS panel of 15 genes. Genologica Medica Spain | 50 | 15 |
|
Genital Abnormalities / Sex Development Disorders Panel Genologica Medica Spain | 95 | 49 |
|
Aromatase deficiency: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.